The loss of Editas Medicine under GAAP for 6 months of 2020 was $61,296 million, down 2.8% from $63,035 million in the previous year. Revenue increased 3.8x to $16,472 mln compared to $4,399 mln a year earlier.
The loss of Editas Medicine under GAAP for 6 months of 2020 was $61,296 million, down 2.8% from $63,035 million in the previous year. Revenue increased 3.8x to $16,472 mln compared to $4,399 mln a year earlier. 
ir.editasmedicine.com
English (US) 